Cite
HARVARD Citation
Maio, M. et al. (n.d.). P863 KEYNOTE-022 parts 4 and 5: pembrolizumab plus trametinib for patients with solid tumors or BRAF wild-type melanoma. Journal for immunotherapy of cancer. pp. A10-A11. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Maio, M. et al. (n.d.). P863 KEYNOTE-022 parts 4 and 5: pembrolizumab plus trametinib for patients with solid tumors or BRAF wild-type melanoma. Journal for immunotherapy of cancer. pp. A10-A11. [Online].